Skip to main content

FATE

Fate Therapeutics Inc

Company with tickers: FATE

Market Cap
$245.36M
Shares Outstanding
116,559,186
CIK
1434316
CUSIP
31189P102
13F Activity (30d)
5 filings 4 filers
Investor Relations
Investor relations

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-05-20 TAHL CINDY 25,590
2026-05-20 Valamehr Bahram 28,946
2026-01-09 Valamehr Bahram 5,190
2026-01-09 TAHL CINDY 10,589
2025-12-29 MENDLEIN JOHN 38,428
2025-08-04 Valamehr Bahram 14,466
2025-08-04 TAHL CINDY 9,037
2025-03-06 Wolchko J Scott 113,178
2025-01-10 TAHL CINDY 5,654
2025-01-10 Bressi Jerome Charles 5,980
2025-01-10 Valamehr Bahram 8,705
2024-12-20 Redmile Group, LLC 341,633
2024-08-06 Xu Yuan 633
2024-03-04 Dulac Edward J III 2,447
2024-01-29 Dulac Edward J III 1,849
2024-01-09 Dulac Edward J III 7,028
2024-01-09 Valamehr Bahram 11,271
2024-01-09 Wolchko J Scott 14,391
2024-01-09 TAHL CINDY 10,874
2024-01-02 Dulac Edward J III 5,182
2023-12-18 Dulac Edward J III 1,585
2023-11-09 TAHL CINDY 24,363
2023-08-18 Dulac Edward J III 4,718
2023-08-04 Xu Yuan 632
2023-07-05 Powl Brian T. 3,854
2023-07-05 Dulac Edward J III 5,182
2023-06-14 Xu Yuan 3,460
2023-04-18 Chu Yu-Waye 2,532
2023-04-14 Redmile Capital Offshore Fund (ERISA), Ltd. 135,134
Showing 1–29 of 29 filings